Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data’s Cogenics Group Installs Protedyne's Robotics System for qPCR and Sequencing Automation

NEW YORK (GenomeWeb News) - Clinical Data said today that its Cogenics services business has installed a Radius Automation from Protedyne for use in qPCR and CLIA sequencing services.
 
Clinical Data's Cogenics unit develops GLP-validated research assays for genotyping, sequencing, qPCR and gene expression research. The group was demarcated as a distinct business unit last year when Clinical Data restructured its operations into three divisions.
 
Cogenics includes capabilities and infrastructure that Clinical Data picked up in its acquisitions of Genaissance, Lark, and Icoria.
 
Cogenics will use Protedyne’s robotic benchtop platform in its services business. Robert Bondaryk, Cogenics’ general manager, said the automated system will support Clinical Data’s Familion Long QT tests and new CLIA sequencing tests developed by its PGxHealth Division.
 
Financial terms of the sale were not disclosed.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.